InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Discover the complete record of transactions filed by Brennan, Paul Anthony. Director active across 1 company, notably Eupraxia Pharmaceuticals Inc.. In total, 1 reports have been logged. History available since 15 December 2025. The latest transaction was disclosed on 15 December 2025 (56 - Grant of rights). Regulator: SEDI. All data is openly available.
1 of 1 declaration